|
π
|
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
78 auth.
Jian Zhou,
Huichuan Sun,
Zheng Wang,
W. Cong,
Jian-hua Wang,
M. Zeng,
Weiping Zhou,
P. Bie,
Lian-Xin Liu,
T. Wen,
G. Han,
Maoqiang Wang,
Ruibao Liu,
Ligong Lu,
Zheng-Gang Ren,
...
Minshan Chen,
Z. Zeng,
P. Liang,
C. Liang,
Min Chen,
Fuhua Yan,
Wenping Wang,
Yuan Ji,
J. Yun,
Dingfang Cai,
Yongjun Chen,
W. Cheng,
Shuqun Cheng,
C. Dai,
Wenzhi Guo,
B. Hua,
Xiaowu Huang,
W. Jia,
Yaming Li,
Yexiong Li,
Jun Liang,
Tianshu Liu,
Guoyue Lv,
Y. Mao,
T. Peng,
W. Ren,
Hongcheng Shi,
G. Shi,
K. Tao,
Wentao Wang,
Xiaoying Wang,
Zhiming Wang,
Bangde Xiang,
B. Xing,
Jianming Xu,
Jiamei Yang,
Jian-yong Yang,
Yefa Yang,
Yunke Yang,
S. Ye,
Zhengyu Yin,
Bixiang Zhang,
Boheng Zhang,
Leida Zhang,
Shuijun Zhang,
Ti Zhang,
Yong-fu Zhao,
Honggang Zheng,
Jiye Zhu,
K. Zhu,
Rong Liu,
Yinghong Shi,
Yong-Sheng Xiao,
Z. Dai,
G. Teng,
J. Cai,
Weilin Wang,
Xiujun Cai,
Qiang Li,
F. Shen,
S. Qin,
Jiahong Dong,
Jia Fan
|
9 |
2020 |
9
π
|
|
π¦
|
Combined Ξ± fetoprotein testing and ultrasonography as a screening test for primary liver cancer
Boheng Zhang,
Bing-hui Yang
|
7 |
1999 |
7
π¦
|
|
π’
|
Prognostic Significance of HIF-1Ξ± Expression in Hepatocellular Carcinoma: A Meta-Analysis
SuSu Zheng,
Xiao-hong Chen,
Xin Yin,
Boheng Zhang
|
6 |
2013 |
6
π’
|
|
π
|
[A prospective study of early detection for primary liver cancer].
7 auth.
Bing-hui Yang,
Boheng Zhang,
Yaochao Xu,
Wenping Wang,
Yuefang Shen,
Anru Zhang,
...
Zhong-Qing Xu
|
6 |
1996 |
6
π
|
|
π’
|
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
Ying Zhou,
Xin Yin,
J. Ying,
Boheng Zhang
|
6 |
2012 |
6
π’
|
|
π
|
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
15 auth.
W. Qiu,
D. David,
Bingsen Zhou,
P. Chu,
Boheng Zhang,
Mengchao Wu,
Jiacheng Xiao,
Tianquan Han,
Zhenggang Zhu,
Tianxian Wang,
...
Xiyong Liu,
R. Lopez,
P. Frankel,
A. Jong,
Y. Yen
|
6 |
2003 |
6
π
|
|
π
|
Ξ³-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma
12 auth.
Hui-Jen Ma,
Lan Zhang,
B. Tang,
Yan Wang,
Rongxin Chen,
Boheng Zhang,
...
Yi Chen,
N. Ge,
Yanβhong Wang,
Y. Gan,
S. Ye,
Z. Ren
|
6 |
2014 |
6
π
|
|
π
|
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
13 auth.
Yan Wang,
Yi Chen,
N. Ge,
Lan Zhang,
Xiaoying Xie,
Ju-bo Zhang,
Rongxin Chen,
Yanβhong Wang,
Boheng Zhang,
J. Xia,
...
Y. Gan,
Z. Ren,
S. Ye
|
5 |
2012 |
5
π
|
|
π
|
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study
11 auth.
Tong-Chun Xue,
Fan Le,
Rongxin Chen,
Xiaoying Xie,
Lan Zhang,
N. Ge,
...
Yi Chen,
Yanβhong Wang,
Boheng Zhang,
S. Ye,
Z. Ren
|
5 |
2015 |
5
π
|
|
π
|
Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
14 auth.
Biwei Yang,
Jing-Huai Zou,
J. Xia,
Z. Ren,
Y. Gan,
Yanβhong Wang,
Boheng Zhang,
N. Ge,
D. Wang,
Yi Chen,
...
Rongxin Chen,
Li-xin Li,
S. Ye,
Xiangdong Wang
|
5 |
2011 |
5
π
|
